PortfoliosLab logoPortfoliosLab logo
MAERSK-B.CO vs. NVZMY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MAERSK-B.CO vs. NVZMY - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in A.P. Møller - Mærsk A/S (MAERSK-B.CO) and Novozymes AS (NVZMY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

MAERSK-B.CO is traded in DKK, while NVZMY is traded in USD. To make them comparable, the NVZMY values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, MAERSK-B.CO achieves a 17.82% return, which is significantly higher than NVZMY's 5.75% return. Over the past 10 years, MAERSK-B.CO has outperformed NVZMY with an annualized return of 13.62%, while NVZMY has yielded a comparatively lower 4.02% annualized return.


MAERSK-B.CO

1D
0.33%
1M
8.80%
6M
16.08%
YTD
17.82%
1Y
32.89%
3Y*
15.42%
5Y*
9.77%
10Y*
13.62%
ALL TIME*
10.90%

NVZMY

1D
0.01%
1M
8.86%
6M
4.70%
YTD
5.75%
1Y
-3.50%
3Y*
10.01%
5Y*
-0.58%
10Y*
4.02%
ALL TIME*
-0.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MAERSK-B.CO vs. NVZMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MAERSK-B.CO
A.P. Møller - Mærsk A/S
17.82%35.07%8.84%-10.06%-24.93%76.90%46.03%19.52%-23.22%-2.48%
NVZMY
Novozymes AS
5.75%0.90%10.88%9.33%-34.62%57.70%7.94%12.86%-17.00%48.90%

Correlation

The correlation between MAERSK-B.CO and NVZMY is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Oct 24, 2007

0.21

The correlation between MAERSK-B.CO and NVZMY shifts across timeframes, from 0.03 (3 years) to 0.21 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MAERSK-B.CO vs. NVZMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MAERSK-B.CO
MAERSK-B.CO Risk / Return Rank: 7171
Overall Rank
MAERSK-B.CO Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
MAERSK-B.CO Sortino Ratio Rank: 6969
Sortino Ratio Rank
MAERSK-B.CO Omega Ratio Rank: 6767
Omega Ratio Rank
MAERSK-B.CO Calmar Ratio Rank: 7373
Calmar Ratio Rank
MAERSK-B.CO Martin Ratio Rank: 7272
Martin Ratio Rank

NVZMY
NVZMY Risk / Return Rank: 3434
Overall Rank
NVZMY Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
NVZMY Sortino Ratio Rank: 3030
Sortino Ratio Rank
NVZMY Omega Ratio Rank: 3030
Omega Ratio Rank
NVZMY Calmar Ratio Rank: 3737
Calmar Ratio Rank
NVZMY Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MAERSK-B.CO vs. NVZMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for A.P. Møller - Mærsk A/S (MAERSK-B.CO) and Novozymes AS (NVZMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MAERSK-B.CONVZMYDifference
Sharpe ratioReturn per unit of total volatility

+1.03

Sortino ratioReturn per unit of downside risk

+1.43

Omega ratioGain probability vs. loss probability

1.18

1.00

+0.18

Calmar ratioReturn relative to maximum drawdown

1.47

-0.15

+1.62

Martin ratioReturn relative to average drawdown

3.21

-0.32

+3.52

MAERSK-B.CO vs. NVZMY - Sharpe Ratio Comparison

The current MAERSK-B.CO Sharpe Ratio is 0.89, which is higher than the NVZMY Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of MAERSK-B.CO and NVZMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MAERSK-B.CO vs. NVZMY - Drawdown Comparison

The maximum MAERSK-B.CO drawdown since its inception was -67.69%, smaller than the maximum NVZMY drawdown of -83.94%. Use the drawdown chart below to compare losses from any high point for MAERSK-B.CO and NVZMY.


Loading charts...

Drawdown Indicators


MAERSK-B.CONVZMYDifference

Max Drawdown

Largest peak-to-trough decline

-67.69%

-83.94%

+16.25%

Max Drawdown (1Y)

Largest decline over 1 year

-22.92%

-22.90%

-0.02%

Max Drawdown (3Y)

Largest decline over 3 years

-34.24%

-29.56%

-4.68%

Max Drawdown (5Y)

Largest decline over 5 years

-53.60%

-47.59%

-6.01%

Max Drawdown (10Y)

Largest decline over 10 years

-63.12%

-47.59%

-15.53%

Current Drawdown

Current decline from peak

-9.31%

-44.14%

+34.83%

Average Drawdown

Average peak-to-trough decline

-25.34%

-50.74%

+25.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.39%

11.37%

-0.98%

Volatility

MAERSK-B.CO vs. NVZMY - Volatility Comparison

A.P. Møller - Mærsk A/S (MAERSK-B.CO) has a higher volatility of 12.14% compared to Novozymes AS (NVZMY) at 7.73%. This indicates that MAERSK-B.CO's price experiences larger fluctuations and is considered to be riskier than NVZMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MAERSK-B.CONVZMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.14%

7.73%

+4.41%

Volatility (6M)

Calculated over the trailing 6-month period

29.62%

18.30%

+11.32%

Volatility (1Y)

Calculated over the trailing 1-year period

37.65%

25.41%

+12.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.27%

26.46%

+14.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.91%

25.93%

+12.98%

Dividends

MAERSK-B.CO vs. NVZMY - Dividend Comparison

MAERSK-B.CO's dividend yield for the trailing twelve months is around 2.86%, more than NVZMY's 1.58% yield.


PositionTTM20252024202320222021202020192018201720162015
MAERSK-B.CO
A.P. Møller - Mærsk A/S
2.86%7.65%4.33%17.23%16.74%1.47%1.15%1.63%1.92%1.45%2.78%3.50%
NVZMY
Novozymes AS
1.58%1.51%1.03%2.68%1.68%0.69%0.91%1.03%1.10%1.64%0.95%0.60%

Financials

MAERSK-B.CO vs. NVZMY - Financials Comparison

This section allows you to compare key financial metrics between A.P. Møller - Mærsk A/S and Novozymes AS. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. MAERSK-B.CO values in DKK, NVZMY values in EUR

Frequently Asked Questions


MAERSK-B.CO and NVZMY have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for MAERSK-B.CO and NVZMY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer